Adenosine Triphosphate (ATP) Assays Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Adenosine Triphosphate (ATP) Assays Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Adenosine Triphosphate (ATP) Assays Market:

https://www.thebusinessresearchcompany.com/report/adenosine-triphosphate-atp-assays-global-market-report

According to The Business Research Company’s Adenosine Triphosphate (ATP) Assays Global Market Report 2024, The adenosine triphosphate (atp) assays market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The  growth in the historic period can be attributed to biomedical research advancements, drug discovery and development, rise in adoption in clinical diagnostics, environmental monitoring requirements, increased focus on cell-based assays..

The adenosine triphosphate (atp) assays market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to continued growth in biopharmaceutical industry, expansion of personalized medicine approaches, increased emphasis on food and beverage safety, technological innovations in assay platforms, growing application in industrial processes.. Major trends in the forecast period include advancements in atp detection technologies, rising demand for high-throughput screening, integration in clinical diagnostics, emphasis on food and beverage safety testing, application in sports and performance monitoring.

The increasing frequency of cancer, chronic, and infectious diseases is expected to propel the growth of the adenosine triphosphate (ATP) assay market going forward. Cancer is characterized by uncontrolled cell growth, which can invade and damage surrounding tissues and potentially spread to other body parts. Chronic diseases are stable conditions that typically progress slowly and persist over an extended period. Infectious diseases are those caused by pathogenic microorganisms that can be spread from person to person, such as bacteria, viruses, fungi, or parasites. ATP assays provide a valuable tool in the diagnostics of these diseases by assessing cellular viability, detecting microbial contamination, evaluating treatment efficacy, and monitoring metabolic and mitochondrial dysfunction. For instance, in October 2022, World Health Organization, a Switzerland-based specialized health agency of the United Nations, roughly 10.6 million people were ill with tuberculosis (TB) in 2021, where 1.6 million people died from TB (including 187 000 HIV positive people). Moreover, in 2021, according to the International Diabetes Federation, a Belgium-based international organization working for the diabetic community, approximately 537 million adults have diabetes, predicted to grow to 783 million by 2045. Therefore, the increasing frequency of cancer, chronic, and infectious diseases propels the adenosine triphosphate (ATP) assay market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10767&type=smp

The adenosine triphosphate (atp) assays market covered in this report is segmented –

1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types

2) By Component: Consumables And Accessories, Instruments

3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions

The development of novel assays is a trend gaining popularity in the adenosine triphosphate (ATP) assay market. Major companies in the ATP assay market are introducing innovative products such as SensiLux kits to sustain their position in the market. For instance, BC Aplicaciones, a Spain-based biotechnology company, launched the SensiLux kit, a testing kit for detecting microbial ATP in a sample. The product is unique as it employs bioluminescence to detect the presence of microbial ATP in a pre-incubated sample. It’s useful for things like food safety testing and contamination testing. It also offers ATP kits with powerful multi-injector automatic luminometers, proprietary control software, and future robot-based sample automation to give customers fully customized solutions. A programming and computer systems department designed and developed unique software to regulate robot and luminometer operations.

The adenosine triphosphate (atp) assays market report table of contents includes:

 

1. Executive Summary
2. Adenosine Triphosphate (ATP) Assays Market Characteristics
3. Adenosine Triphosphate (ATP) Assays Market Trends And Strategies
4. Adenosine Triphosphate (ATP) Assays Market – Macro Economic Scenario
5. Global Adenosine Triphosphate (ATP) Assays Market Size and Growth

 

.

.

.

31. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking
32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Adenosine Triphosphate (ATP) Assays Market
34. Adenosine Triphosphate (ATP) Assays Market Future Outlook and Potential Analysis
35. Appendix

Top Major Players:

• Merck KgaA
• PerkinElmer Inc
• Lonza Group
• Promega Corporation
• Agilent Technologies Inc.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model